While known to be overexpressed in breast cancers, the relatively higher expression of BIRC5 observed among our high-risk patients (q = 1.37× 10−178) (Supplementary Table 5) suggests there is a tipping point of mRNA abundance leading to increased risk. Here, BIRC5 is linked to breast carcinoma.